Navigation Links
Ikaria(R) Strengthens Research & Development Team
Date:7/1/2008

Appoints Dr. Deborah Petrowsky Vice President of Medical Affairs and Dr.

Steven Knapp Vice President of Regulatory Affairs

CLINTON, N.J., July 1 /PRNewswire/ -- Ikaria Holdings, Inc., a fully integrated critical care biotherapeutics company, announced today the addition of two executives to its Research & Development division. Deborah Petrowsky, M.D., F.C.C.P. was named Vice President for Medical Affairs and Steven Knapp, M.S., Pharm.D. was appointed Vice President of Regulatory Affairs. Both will report directly to Ralf Rosskamp, M.D., Executive Vice President for Research and Development of Ikaria.

Dr. Rosskamp commented, "Deborah and Steven are valuable additions to our R&D team. Deborah brings with her extensive clinical experience in the critical care setting and a deep understanding of the crucial role of Medical Affairs in developing and maintaining relationships with our most influential customers. In addition, she has forged strong professional relationships in the Pulmonary and Endocrine Community and worked closely with the clinical teams on sponsor-initiated Phase 3b/4 studies.

"Steven has a proven track-record of successful interactions with regulatory authorities worldwide and has been an accomplished team player on many company project teams and inter-company alliance teams. He has significant expertise in regulatory due-diligence activities, which will help us to identify promising in-licensing candidates for Ikaria. I look forward to working with both Deborah and Steven as we continue to move our development pipeline forward."

Daniel Tasse, President & CEO of Ikaria, remarked, "Because we have a deep, very active product pipeline, it is vital that we have strong Medical and Regulatory Affairs teams in place. Deborah and Steve bring a wealth of experience in their respective areas of expertise to the R&D team, and we are very pleased that they have elected to join Ikaria. I am certain that they will pro
'/>"/>

SOURCE Ikaria Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. Kenyan malaria success strengthens call for free insecticide-treated nets for all
2. International study strengthens case for daily calcium pill
3. Wachovia Strengthens Its Healthcare Industry Receivables and Cash Management Capabilities
4. Essilor Strengthens its Polarized Lens Distribution Network With the Acquisition of KBco
5. Publicis Groupe Strengthens its Leadership in Digital and Integrated Healthcare Communications in Italy
6. NIAID strengthens and expands Vaccine and Treatment Evaluation Units
7. Pieris Strengthens its Management, as it Prepares for the Clinical Development of PRS-050, an Anticalin(R)-Based Novel Cancer Therapy
8. Rosetta Genomics Strengthens Senior Management in Preparation for its First Commercial Launch of microRNA-Based Diagnostic Products in 2008
9. Start Licensing, Inc. Further Strengthens Position in Cloning Industry With New Patents
10. Scientx USA Strengthens Leadership Team With Appointment of Bryce IntVeld as Vice President of Sales
11. Dowden Custom Media Strengthens e-Media

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... , , WASHINGTON, Nov. 21 /PRNewswire-USNe...wing statement after the Senate voted to begin ful...,, (Logo: http://www.newscom.com/cgi-bin/prnh/... another historic step on the road to enacting hea...dural hurdle, senators will now have an opportunit...
(Date:11/21/2009)... , , WASHINGTON, Nov. 21 /PRNewswire-USN...1990s to eliminate onchocerciasis (river blindness...evalence of the disease in recent years, as eviden... requiring mass drug administration in six endemic...th annual meeting of the American Society of Tropi...
(Date:11/21/2009)... , NH based medical crede... first in its industry to form a partnerhsip with ...he U.S. This partnership will help to transform q... (Vocus) November 21, 2009 -- IS... has announced a new agreement with Amerinet Inc.,...
(Date:11/21/2009)... , Eric J. Hall, presiden...oundation of America (AFA) issued the following st...rment detection as part of the new annual wellness...rotection and Affordable Care Act" that was i...ew York, NY (PRWEB) November 21, 2009 -- Eric J. H...
(Date:11/20/2009)... , , Pioneering Neurologist Closer to Unde...ON, Nov. 20 Dr. Jeremy ...cal School and neurologist at the Massachusetts Ge..., presented his laboratory,s research on the new f...of the MINDlink Foundation. ,, Dr. Schmahmann i...
Breaking Medicine News(10 mins):Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2
...obstructive sleep apnea, a sleep disorder that cau...s a night and appears to also promote bed-wetting ...sociate professor of pediatrics at the University ...lems at night, 66 children (41 percent) were also ...
...nstant stress can make people sick, and now a team...ocused on 119 men and women who were taking care o...ers was compared with that of 106 people of simila...blood of the stressed caregivers compared with blo...
...ive findings in a new study that looked at the rol... medical errors involving medications. The inves...e in medical rounds with doctors resulted in t...in the hospital, an area where previous studies ha...
...appears to prevent or delay the onset of prostate ...he growth of high-grade cancers. More than 18,...teride 5 mg/day or placebo. At baseline, digital r... the finasteride group treated for 7 years, prosta...
...rbilt University shows cholesterol-lowering effect...tea. The study is the first placebo-controlled cli...operties of tea in humans. Studies of large po...nship between tea and lower levels of cholesterol ...
...the ongoing Nurses Health Study II suggest women w...ach day may decrease their risk of developing type...intake has produced conflicting results, with most...a positive effect //because alcohol increases insu...
Other Medicine News:Health News:Sleep Apnea Linked to Bed-Wetting in Kids 2
(Date:11/20/2009)... , NEW YORK, Nov. 20 Report...port is available in its catalogue. ,, Pipette..., http://www.reportlinker.com/p0164373/Pipett...tm_source=prnewswire&utm_medium=pr&utm_cam...e treated as an integral part of any research labo...
(Date:11/20/2009)... , NEW YORK, Nov. 20 ,, ...rch report is available in its catalogue. ,, G..., http://www.reportlinker.com/p0164741/Global-Ma...ce=prnewswire&utm_medium=pr&utm_campaign=p...opsy devices includes the spring loaded core needl...
(Date:11/20/2009)... , NEW YORK, Nov. 20 Report...port is available in its catalogue. ,, Medical..., http://www.reportlinker.com/p0164242/Medical-A...m_source=prnewswire&utm_medium=pr&utm_camp...es and sealants is gaining preeminence in medical ...
Breaking Medicine Technology:Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Reportlinker Adds Global Markets for Breast Biopsy Devices 2009 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6Sevocity EHR 08 Released With ARRA 28Stimulus 29 Commitment 13737 1Sevocity EHR 08 Released With ARRA 28Stimulus 29 Commitment 13737 2Tianyin Pharmaceutical Co to Present at the Rodman 26 Renshaw Annual Global Investment Conference on September 11 at 10 3A50 am ET 13735 1Tianyin Pharmaceutical Co to Present at the Rodman 26 Renshaw Annual Global Investment Conference on September 11 at 10 3A50 am ET 13735 2Tianyin Pharmaceutical Co to Present at the Rodman 26 Renshaw Annual Global Investment Conference on September 11 at 10 3A50 am ET 13735 3Sundia Receives the Highest Growth Potential Award from Zhangjiang 55681 1Sundia Receives the Highest Growth Potential Award from Zhangjiang 55681 2
...SAN FRANCISCO, Dec. 17 Medivation, Inc.,(Nasdaq: ...ient enrollment in a,Phase 1-2 dose-escalation cli...r antagonist, in castration-resistant prostate can...the U.S. Food and Drug Administration (FDA) to,adv... The open-label, U.S. Phase 1-2 study evaluated pr...
...EMERYVILLE, Calif., Dec. 17 Neurobiological,Techn...ounced that an independent,Data Safety Monitoring ...cal,trials of Viprinex(TM) for the treatment of ac...As a result, the company has terminated further en...e the data before evaluating the,potential for any...
Other Medicine Technology:Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 2Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 3Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 4Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis 2
...g; 96 and E-Gel® 48 gels run in the specially ...h combine the base and power supply in one device.... mother E-Base™ and to other daughter E-Base...esis of two or more E-Gel® 96 or E-Gel® 48...
...lder™ Platform is designed with a spring-loa... E-Gel® 48 gel cassettes stay firmly in place ...lacement and loading from one gel to the next with...g software. In addition, the E-Holder™ Platf...
...units can be used for: Analytical Protein and Pept...g SDS-PAGE gels IEF in ultrathin PAGE gels (Z64,07... Peptide Separation: Non-denaturating PAGE gels an...071-9& Z64,075-1) Molecular Biology: DNA/RNA fragm...
...set up and safe to use, the Gel XL Ultra includes ...garose gels. The unit is compact, requiring a mini...r supply eliminates a tangled mess of leads and co...ety and convenience, the power supply can detect w...
Medicine Products: